StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Total U.S. Industry MAUDE Device Adverse Event Reports by Quarter

Total U.S. Industry MAUDE Device Adverse Event Reports (U.S. Industry Total MDRs)

Thermo Fisher Scientific Total U.S. Industry MAUDE Device Adverse Event Reports: 1,189,467 in Q3 2026, up 45.2% from a year earlier. That is the highest of the 43 quarters on record here.

Latest, Q3 2026
1,189,467
Period ended Sep 30, 2026
Change on a year earlier
+45.2%
819,444 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
1
openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total

Where the Q3 2026 figure comes from

Source: openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗

Reported in U.S. FDA openFDA MAUDE Adverse Event API.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal U.S. Industry MAUDE Device Adverse Event Reports (U.S. Industry Total MDRs)Year on yearSource
Q3 2026Sep 30, 20261,189,467+45.2%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q2 2026Jun 30, 2026923,529+46.1%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q1 2026Mar 31, 2026811,618+18.4%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q4 2025Dec 31, 2025751,012+5.9%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q3 2025Sep 30, 2025819,444+17.1%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q2 2025Jun 30, 2025632,296+0.1%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q1 2025Mar 31, 2025685,251+16.9%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q4 2024Dec 31, 2024709,498+23.7%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q3 2024Sep 30, 2024699,798+15.9%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q2 2024Jun 30, 2024631,546+8.3%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q1 2024Mar 31, 2024586,309+1.2%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q4 2023Dec 31, 2023573,619+2.7%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q3 2023Sep 30, 2023603,602-5.7%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q2 2023Jun 30, 2023583,295-35.9%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q1 2023Mar 31, 2023579,290-30.8%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗
Q4 2022Dec 31, 2022558,725-2.8%openFDA MAUDE Adverse Event Reports — U.S. Device Industry Total ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Total U.S. Industry MAUDE Device Adverse Event Reports, quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fda-maude-industry

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.